Editor-in-Chief

Athanasios E. Athanasiou, Department of Medical Oncology, Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece

Associate Editors

  • Sinisa Radulovic, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, 11000
  • Lei Yang, Department of Orthopedics, Nanjing Medical University, China
  • Strashimir Karanov, National Cancer Center hospital, Sofia, 1756 Bulgaria
  • Munir Kinay, Chairman of Dokuz Eylul University Oncology Institute at Dokuz Eylul University, Izmir, Turkey
  • Dimitrios Trafalis, Medical Oncologist at University of Athens, School of Medicine, Athens, Greece
  • Dimitrios Moris, Department of Surgery, Duke University Medical Center, Durham, NC, USA

English Editor: Constantinos E. Alifieris, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Editorial Office: editorial_office@jbuon.com

Editorial Board

  • P. Achimas-Cadariu, Faculty of Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • M. Alakavuklar, Department of Medical Oncology, Kent Hospital, Izmir, Turkey
  • I. Alexandru, Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania
  • K. Altundag, MKA Breast Cancer Clinic, Ankara, Turkey
  • G. Androutsos, Biomedical Research Foundation, Academy of Athens, Athens, Greece
  • R. Anghel, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
  • J.P. Armand, Medical Oncology, Institute Gustave Roussy and Institute Curie, Toulouse, France
  • J.O. Armitage, University of Nebraska Medical Center, Omaha, USA
  • N. Arsenijević, Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
  • R.C. Bast Jr, Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, USA
  • A. Bikfalvi, University of Bordeaux, Pessac, France
  • G. Bogdanović, Department of Experimental Oncology, Institute of Oncology Sremska Kamenica, Serbia
  • N. Bountouroglou, Department of Radiation Oncology-A, Metaxa Cancer Hospital, Piraeus, Greece
  • M. Branković-Magić, Institute for Oncology and Radiology of Serbia, Beograd, Yugoslavia
  • S. Brkić, University of Novi Sad, Faculty of Medicine, Serbia
  • P.A. Bunn Jr, Division of Medical Oncology, University of Colorado, Denver, USA
  • K. Christov, Department of Surgical Oncology and Cancer Center, University of Illinois at Chicago, Chicago, USA
  • T. Ciuleanu, Oncology Institute Ion Chiricuta, Cluj-Napoca, Romania
  • D. Delgado, Health & Territory Research of the Universidad de Sevilla, Seville, Spain
  • H.-J. Li, Affiliated 5 to Nantong University, Taizhou, China
  • V. Diehl, University Clinics Cologne, Koln, Germany
  • C. Dittrich, Kaiser Franz Josef-Spital, Vienna, Austria
  • T. Dragovich, University of Arizona Cancer Center, Tucson, USA
  • I. Duran, Hospital Universitario Virgen del Rocio, Seville, Spain
  • A. Eniu, Department of Breast Tumours, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania
  • S. Filipović, University of Nis, Faculty of Medicine, Clinic of Oncology, Nis, Serbia
  • E.J. Freirech, The University of Texas, MD Anderson Cancer Center, Houston, USA
  • X.-J. Cao, Jiangsu Province Hospital, Nanjing, China
  • C. Gavrilovic, Institute for Oncology and Radiology of Serbia, Beograd, Serbia
  • G. Geromichalos, Laboratory of Inorganic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • L. Gocheva, University Hospital “Queen Giovanna-ISUL” Department of Radiotherapy, Sofia, Bulgaria
  • A. Perin, Institute for Pulmonary Diseases of Vojvodina,  University of Novi Sad, Topolsica, Slovenia
  • A. Grivas, Department of Medical Oncology, Metaxa Cancer hospital, Piraeus, Greece
  • S. Guadagni, Department of Applied Clinical Sciences and Biotechnology, University of L’Aquila, L’Aquila, Italy
  • S.Guler, Kocaeli University Medical Faculty, Dept.of General Surgery, Izmir, Turkey
  • H. Hansen, Department of Oncology, Finsen Centre, Copenhagen, Denmark
  • A. Haydaroglu, Department of Radiation Oncology, Ege University Faculty of Medicine, Izmir, Turkey
  • J.C. Holland, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, USA
  • J.C. Horiot, Centre Georges-François Leclerc, Dijon, France
  • R. Igić, Department of Anesthesiology and Pain Management, Stroger Hospital of Cook County, Chicago, USA
  • A. Irimie, Department of Surgery, The Oncology Institute “Prof. Dr. Ion Chiricuta”, Cluj-Napoca, Romania
  • L. Wan, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, China
  • G. Karikas, Department of Medical Laboratories, Faculty of Health and Caring Professions, Technological Educational Institute of Athens, Athens, Greece
  • S.B. Kaye, Department of Medical Oncology, University of Glasgow, Garcube Estate, Glasgow, UK
  • A. Klein, Institute of Oncology, Meir Medical Center, Kfar Saba, Israel
  • M. Kontos, First Department of Surgery, ‘Laikon’ General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
  • E. Lianos, Department of Medical Oncology A’, “Metaxa” Cancer Hospital, Piraeus, Greece
  • S. Linardopoulos, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK
  • I. Lubinski, Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Center, Szczecin, Poland
  • V. Malamou-Mitsi, Department of Pathology, University of Ioannina School of Medicine, Ioannina, Greece
  • M. Malumbres, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
  • L. Yang, Nanjing Medical University, Nanjing, China
  • A. Mandić, University of Novi Sad, School of Medicine, Novi Sad, Serbia
  • G. Marjanović, Department of Haematology and Clinical Immunology, Clinical Center Nis and Medical Faculty, University of Nis, Nis, Serbia
  • J. Meletis, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece
  • L. Miron, Department of Clinics, Faculty of Veterinary Medicine, Iasi, Romania
  • A. Molassiotis, School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK
  • A. Nersesyan, Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
  • L. Ozguroglu, Istanbul University, Cerrahpasa Medical Faculty, Division of Medical Oncology, Istanbul, Turkey
  • A.D. Purushotham, Cambridge Breast Unit, Addenbrookes Hospital, Cambridge, UK
  • D. Radosavljević, Department of Medical Oncology, University of Belgrade, Belgrade, Serbia
  • D. Raghavan, Cleveland Clinic Taussig Cancer Center, 9500 Euclid Avenue Cleveland, Ohio, USA
  • G. Rigatos, St. Savas Anticancer Hospital, Athens, Greece
  • S. Ruacan, Department of Pathology, Medical Faculty of Hacettepe University, Ankara, Turkey
  • P. Rusu, Department of Radiotherapy, Institute of Oncology Prof. Ion Chiricuta, Cluj-Napoca, Romania
  • S. Sahin, Diskapi Yildirim Beyazit Training and Research hosp., Dept of Medical Oncology, Ankara, Turkey
  • M. Sakizli, Medical Biology and Genetics Department, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey
  • M.A.N Sendur, Faculty of Medicine, Department of Medical Oncology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey
  • J.F. Smyth, Cancer Research Centre Western General Hospital, University of Edinburgh, Edinburgh, UK
  • D. Spandidos, Medical School, University of Crete, Heraklion, Crete, Greece
  • J. Syrios, Department of Medical Oncology A’, “Metaxa” Cancer Hospital, Athens, Greece
  • I. Tannock, Division of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada
  • L. Teppo, Finnish Cancer Registry, Helsinki, Finland
  • A. Thanos, Department of Urology, General Hospital of Athens, Athens, Greece
  • E. Tsiambas, Department of Cytology, 417 Veterans Army Hospital (NIMTS), Athens, Greece
  • D. Tural, Department of Internal Medicine, Division of Medical Oncology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • A.T. Van Oosterom, Department of Oncology, University Hospitals Leuven, Leuven, Belgium
  • J.B. Vermorken, Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium
  • S.G. Vitale, University of Messina, Catania, Italy
  • C. Vlad, Department of Oncology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • P.A. Voûte, Emma Kinderziekenhuis, Academic Medical Center, Amsterdam, The Netherlands
  • E. Wagner, Nanosystems Initiative Munich (NIM), Munich, Germany
  • J. Tang, Department of Plastic Surgery, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
  • D. Yannoukakos, Molecular Diagnostics Laboratory, I/RRP, National Centre for Scientific Research Demokritos, Athens, Greece
  • Alparslan Merdin, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey
  • R.F. Ozols, Medical Science Department, Fox Chase Cancer Center, Philadelphia, USA
  • G. Panagos, Department of Medical Oncology, Agii Anargiri Cancer Hospital, Kifisia, Athens, Greece
  • H.M. Pinedo, Department of Medical Oncology, VU University Medical Center,  Amsterdam, The Netherlands

Reset link sent!

Link for password reset has been emailed to you. Please check your email.